Dr Namasivayam AmbalavananSMALL 22

Co-Director, Division of Neonatology
Director, Sergio B. Stagno Research Endowment
Director, Neonatal Research
Program Director, Neonatal-Perinatal Fellowship Program
Director, TReNDD Program
Director, Neonatal Research
Director, Rare Disease Program
Division of Neonatology


Jawaharlal Institute of PostGraduate Medical Education and Research (JIPMER)

Pondicherry, India MBBS, Medical Degree


JIPMER Pondicherry, India; Internship

Chandigarh, India; Post Graduate Institute of Medical Education and Research (PGIMER) MD (Pediatrics)

University of Alabama at Birmingham; Neonatology fellowship

University of Alabama at Birmingham; Pediatric residency


As Director of the Translational Research in Normal and Disordered Development (TReNDD) Program and the Division of Neonatal Research at the University of Alabama at Birmingham, I lead a basic science laboratory with a research focus on mechanisms underlying normal lung development and lung injury, in addition to managing and directing single center and multicenter observational and interventional clinical studies in critically ill neonates. The University of Alabama at Birmingham is a regional perinatal center, and our center is a member of the NICHD Neonatal Research Network (I am alternate center PI), the Global Network, and the MFMU Network. In the Neonatal Research Network, I am co-chair of the Genomics subcommittee and the Probiotics subcommittee, and serve on the Late Hypothermia, Diuretics, MoCHA, and high dose caffeine subcommittees. I have >220 publications to date, of which 80 are as first or senior author. I have expertise in training pre-doctoral and post-doctoral scientists, and have contributed in recent years to the training of multiple junior faculty (including one with a current K08, one with R01 funding, one with an AHA SDG, and one with industry funding), multiple T32 programs and the T35 Short Term Research in Pediatrics for Medical Students program. The focus of my clinical/translational research is on biomarkers and prediction of outcomes in premature infants. I am PI of one of four research centers in the LungMAP project funded by the NIH, and PI of one of five research centers in the Pre-VENT project also funded by the NIH. I am funded by the NHLBI for STOP BPD, a project to evaluate resilience and predisposition to BPD using genomic, proteomic, and airway microbiomic profiles.